Can Lisinopril Cause Weight Gain?
Lisinopril does not cause weight gain; in fact, it is associated with modest weight loss. This makes it an excellent choice when weight concerns are present in patients requiring antihypertensive therapy.
Evidence from Clinical Trials and FDA Data
- The FDA-approved drug label for lisinopril does not list weight gain as an adverse reaction in clinical trials of hypertension or heart failure patients 1.
- Common adverse reactions (≥2% greater than placebo) in hypertension trials included headache, dizziness, and cough—but not weight changes 1.
- In heart failure trials, the most common adverse reactions were hypotension and chest pain, with no mention of weight gain 1.
Recent Comparative Effectiveness Research
The most robust recent evidence comes from a 2025 comparative effectiveness study that directly examined weight change across antihypertensive medications:
- Lisinopril was associated with weight loss at all time points: -0.69 kg at 6 months, -0.58 kg at 12 months, and -1.12 kg at 24 months 2.
- When compared to lisinopril, other antihypertensives showed greater weight gain: metoprolol (+1.38 kg at 6 months, +1.74 kg at 12 months), propranolol (+1.03 kg at 6 months, +1.72 kg at 12 months), hydrochlorothiazide (+0.68 kg at 6 months), and losartan (+0.54 kg at 6 months) 2.
- This study analyzed 141,260 patients across 8 US health systems, providing high-quality real-world evidence 2.
Mechanistic Support
- A 2015 systematic review and meta-analysis of 257 randomized trials found that ACE inhibitors like lisinopril were not associated with statistically significant weight change, unlike many other drug classes 3.
- Animal studies demonstrate that ACE inhibitors like enalapril (a related drug) actually decrease body weight gain through metabolic modulation of adipose tissue 4.
Clinical Guideline Context
European guidelines specifically note that beta-blockers (not ACE inhibitors) favor weight gain and should be avoided in patients with metabolic syndrome 5:
- Beta-blockers "favour an increase in weight" and increase the incidence of new-onset diabetes 5.
- ACE inhibitors are specifically recommended for patients with metabolic syndrome, diabetes, and obesity-related conditions—populations where weight-neutral or weight-reducing medications are preferred 5.
Common Pitfall to Avoid
Do not confuse lisinopril with beta-blockers or thiazide diuretics, which are the antihypertensive classes truly associated with weight gain 5, 2. If a patient reports weight gain after starting "blood pressure medication," verify which specific agent was prescribed, as the class matters significantly for this adverse effect.